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There is evidence that high fructose diets can lead to the
development of obesity, insulin resistance, and dyslipidemia
in rodents model. In humans, however, the role of fructose
in the recent increase in the prevalence of metabolic
diseases remains much debated. Several epidemiological
studies show a positive relationship between consumption
of added sugar, fructose, or sweetened beverages on one
hand, and metabolic disorders on the other hand, but fail
to conclusively prove a causal relationship. Several short
term overfeeding studies show that a high fructose diet
can, over a short period of time, increase plasma triglycer-
ide concentrations and in intra-hepatocellular lipid concen-
trations, stimulate hepatic de novo lipogenesis, modestly
increase endogenous glucose production, and enhance
post-glucose glycemic responses. Whether these studies
are relevant to the pathophysiology of the metabolic syn-
drome is however not known, and several important issues
remain however to be addressed. More specifically,
whether consumption of fructose causes metabolic disor-
ders when consumedas part of an energy-balanced diet is
not known. The interactions between fructose intake and
other environmental factors such as other macronutrients
or physical activity have also not been addressed. This pre-
sentation will summarize the present knowledge regarding
the metabolic effects of short term high fructose diets in
humans. Novel data will be presented to support that a
high fructose diet increases plasma triglycerides indepen-
dently of energy balance. Finally, the influence of other
environmental factors (dietary protein intake, exercise) on
the metabolic effects of fructose will be presented.
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